Fidelity Disruptive Medicine ETF
FMED
12 hedge funds and large institutions have $42.8M invested in Fidelity Disruptive Medicine ETF in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
71% more funds holding
Funds holding: 7 → 12 (+5)
16% more capital invested
Capital invested by funds: $37M → $42.8M (+$5.75M)
1.6% more ownership
Funds ownership: 66.59% → 68.19% (+1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$1.2M |
| 2 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$852K |
| 3 |
BW
BXM Wealth
Englewood,
Colorado
|
+$242K |
| 4 |
VT
Vise Technologies
New York
|
+$233K |
| 5 |
VF
Virtu Financial
New York
|
+$227K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$14.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $19.8M | +$135 | +5 | +0% |
|
|
2
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
| $19.7M | +$852K | +31,629 | +5% |
|
|
3
Jane Street
New York
| $2.47M | +$1.2M | +44,630 | +95% |
|
|
BW
4
BXM Wealth
Englewood,
Colorado
| $243K | +$242K | +8,990 | New |
|
|
VT
5
Vise Technologies
New York
| $234K | +$233K | +8,648 | New |
|
|
VF
6
Virtu Financial
New York
| $228K | +$227K | +8,424 | New |
|
|
GJIA
7
Glass Jacobson Investment Advisors
Owings Mills,
Maryland
| $34.1K | +$10.4K | +385 | +44% |
|
8
BlackRock
New York
| $31.2K | +$31.1K | +1,154 | New |
|
|
9
UBS Group
Zurich,
Switzerland
| $5.98K | -$14.5K | -540 | -71% |
|
|
CPBTD
10
Central Pacific Bank - Trust Division
Honolulu,
Hawaii
| $2.62K | – | – | – |
|
|
GEA
11
Glen Eagle Advisors
Kingston,
New Jersey
| $2.44K | – | – | – |
|
|
QA
12
Quattro Advisors
Pittsburgh,
Pennsylvania
| $48 | +$54 | +2 | New |
|
FMED Hedge Fund Activity: Q4 2025 in Review
12 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Fidelity Disruptive Medicine ETF (FMED) for Q4 2025, worth a combined $42.8M — up 16% from $37M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new FMED positions and 0 closed out — a net gain of 5 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, adding an estimated $1.2M. The largest seller was UBS Group, cutting an estimated $14.5K.
- 12 institutional investors held Fidelity Disruptive Medicine ETF (FMED) as of Q4 2025, up from 7 in Q3 2025.
- Funds reported $42.8M of Fidelity Disruptive Medicine ETF stock for Q4 2025, up 16% quarter-over-quarter.
- 5 funds opened new Fidelity Disruptive Medicine ETF positions in Q4 2025 and 0 closed out, a net change of +5 holders.
- The largest Fidelity Disruptive Medicine ETF buyer in Q4 2025 was Jane Street, an estimated $1.2M added.
- The largest Fidelity Disruptive Medicine ETF seller in Q4 2025 was UBS Group, an estimated $14.5K sold.
Based on aggregated 13F filings for Q4 2025.